CDMO Samsung Biologics Invests in Antibody-Drug Conjugates Firm AimedBio
Samsung Biologics, the world’s largest contract development and manufacturing organization (CDMO) by capacity, has invested in AimedBio, a Korean biotech firm specializing in antibody-drug conjugates. The equity investment was made…